Patents by Inventor Carsten Kirschning

Carsten Kirschning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13
    Publication number: 20170137820
    Abstract: The present invention relates to the field of immunology. The present invention provides agonists and antagonists of Toll-like receptor (TLR) 13. In particular, the present invention provides TLR13 activating and inhibiting nucleic acids, and provides such nucleic acids for use as pharmaceutical agents. The present invention further provides in vitro methods using such nucleic acids.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 18, 2017
    Applicant: Bavarian Nordic A/S
    Inventors: Carsten Kirschning, Stefan Bauer, Hubertus Hochrein
  • Agonists and antagonists of toll-like receptor (TLR) 13
    Patent number: 9556439
    Abstract: The present invention relates to the field of immunology. The present invention provides agonists and antagonists of Toll-like receptor (TLR) 13. In particular, the present invention provides TLR13 activating and inhibiting nucleic acids, and provides such nucleic acids for use as pharmaceutical agents. The present invention further provides in vitro methods using such nucleic acids.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: January 31, 2017
    Assignee: BAVARIAN NORDIC A/S
    Inventors: Carsten Kirschning, Stefan Bauer, Hubertus Hochrein
  • AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13
    Publication number: 20140377309
    Abstract: The present invention relates to the field of immunology. The present invention provides agonists and antagonists of Toll-like receptor (TLR) 13. In particular, the present invention provides TLR13 activating and inhibiting nucleic acids, and provides such nucleic acids for use as pharmaceutical agents. The present invention further provides in vitro methods using such nucleic acids.
    Type: Application
    Filed: February 8, 2013
    Publication date: December 25, 2014
    Inventors: Carsten Kirschning, Stefan Bauer, Hubertus Hochrein